CO-CREATION IDEA: Please offer a brief description of how you imagine a win-win partnership with Boehringer Ingelheim to better serve unmet needs in health. (Hint: Please mention the underlying business model envisioned that would make such a partnership sustainable.)
Our partnership with Boehringer Ingelheim (BI) as anticipated will be the beginning of a mutually beneficial relationship. While it is expected that "Waste-Undertaker" (WU) will enjoy funding and possible technical supports from BI, opportunities for drug patronage will be opened for exploration either directly from WU to improve their impacts within the vulnerable population or other drug-seeking clients in Nigeria or better still, across Africa. Opportunities to better serve unmet needs in health are inexhaustible and in this circumstance, BI will have access to new markets, get better knowledge about the project and possible new research areas while WU will reciprocate by replicating the project nationwide thus, impacting more lives.
NEEDS: Based on you response above, please specify which of the following resources, operations or expertise by Boehringer Ingelheim you imagine leveraging to actualize the proposed co-creation opportunity. Please check all that apply. (Hint: while financing is often critical to scale, we are also interested in understanding what other assets or expertise could be leveraged).
Distribution Channels, Research and Development, Specific Disease Expertise, Relationships/New Contacts, Manufacturing, Human Resources, Legal Support, Technology Expertise, Public Policy Knowledge, Access to Capital.
EXPLANATION OF NEEDS: Please explain your choices in more detail.
This project essentially needs capital for its establishment and full operation until it is financially sustainable. Equipments and other materials are pressing issues in the project which are needed to be procured and put in place for commencement and smooth operation.
Human resources will be harnessed locally for the start-up, new contacts and relationships will be necessary as a precursor towards seeking supports in scaling this innovation while the legal and government policy as required will equally be sourced accordingly.
When manufacturing is considered technology expertise is requi.
OFFER: What are the main assets you may contribute in a co-creation partnership with Boehringer Ingelheim that would better serve unmet needs in health?
Deep understanding of an unmet need in a specific market/context, Access to and established trust with customers/beneficiaries, Insights into pricing and financing of health products/services, Insights into marketing, Insights into distribution, Insights into behavior change.
FOCUS AREAS: Which of the following best describes the main focus of your project? (select all that apply)
Improving the affordability of healthcare (e.g., microinsurance, reducing the economic cost of care), Increasing physical access to healthcare to people with restricted mobility or restricted access (senior people, people with disability, remote or difficult areas, etc.), Holistic solutions that work across the entire care continuum (including education, prevention, detection, treatment, management, follow-up), Models that engage other industry players (e.g., nutrition, athletic, mobility organizations)., Remote care solutions for health management, treatment, and diagnosis, Packaging of health products and services to address needs currently unmet.